| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |